Detalhe da pesquisa
1.
A virtual audit system for intensity-modulated radiation therapy credentialing in Japan Clinical Oncology Group clinical trials: A pilot study.
J Appl Clin Med Phys
; 24(6): e14040, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37191875
2.
S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
Ann Surg Oncol
; 29(13): 8198-8206, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097299
3.
Study protocol for JCOG1807C (DEEP OCEAN): a interventional prospective trial to evaluate the efficacy and safety of durvalumab before and after operation or durvalumab as maintenance therapy after chemoradiotherapy against superior sulcus non-small cell lung cancer.
Jpn J Clin Oncol
; 52(4): 383-387, 2022 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999817
4.
Multicenter prospective study of stereotactic body radiotherapy for previously untreated solitary primary hepatocellular carcinoma: The STRSPH study.
Hepatol Res
; 51(4): 461-471, 2021 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-33217113
5.
A multi-institutional randomized phase III trial comparing postoperative radiotherapy to observation after adjuvant chemotherapy in patients with pathological N2 Stage III non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1916 (J-PORT study).
Jpn J Clin Oncol
; 51(6): 999-1003, 2021 May 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-33772279
6.
A multi-institutional randomized phase III study comparing weekly carboplatin plus nab-paclitaxel and daily low-dose carboplatin as regimens for concurrent chemoradiotherapy in elderly patients with unresectable locally advanced non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG1914.
Jpn J Clin Oncol
; 51(5): 836-841, 2021 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33728436
7.
A phase II study of adaptive two-step intensity-modulated radiation therapy (IMRT) with chemotherapy for loco-regionally advanced nasopharyngeal cancer (JCOG1015).
Int J Clin Oncol
; 25(7): 1250-1259, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32221802
8.
Single-arm confirmatory trial of postoperative concurrent chemoradiotherapy using intensity modulated radiation therapy for patients with high-risk uterine cervical cancer: Japan Clinical Oncology Group study (JCOG1402).
Jpn J Clin Oncol
; 49(9): 881-885, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31613355
9.
Nimotuzumab combined with concurrent chemoradiotherapy in Japanese patients with esophageal cancer: A phase I study.
Cancer Sci
; 109(3): 785-793, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29285832
10.
Final report of survival and late toxicities in the Phase I study of stereotactic body radiation therapy for peripheral T2N0M0 non-small cell lung cancer (JCOG0702).
Jpn J Clin Oncol
; 48(12): 1076-1082, 2018 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30277519
11.
ASO Visual Abstract: S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II Trial.
Ann Surg Oncol
; 29(13): 8209-8210, 2022 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36209323
12.
A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial).
Jpn J Clin Oncol
; 47(3): 277-281, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28073946
13.
A phase I/II study on stereotactic body radiotherapy with real-time tumor tracking using CyberKnife based on the Monte Carlo algorithm for lung tumors.
Int J Clin Oncol
; 22(4): 706-714, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28429140
14.
Esophageal stenosis and the Glasgow Prognostic Score as independent factors of poor prognosis for patients with locally advanced unresectable esophageal cancer treated with chemoradiotherapy (exploratory analysis of JCOG0303).
Int J Clin Oncol
; 22(6): 1042-1049, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28717855
15.
Feasibility study of chemoradiotherapy followed by amrubicin and cisplatin for limited-disease small cell lung cancer.
Cancer Sci
; 107(3): 315-9, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26748638
16.
Inter-institutional survival heterogeneity in chemoradiation therapy for esophageal cancer: exploratory analysis of the JCOG0303 study.
Jpn J Clin Oncol
; 46(4): 389-92, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26830150
17.
Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A).
Jpn J Clin Oncol
; 46(8): 748-53, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27174959
18.
Randomized study of low-dose versus standard-dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303).
Cancer Sci
; 106(4): 407-12, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25640628
19.
Definitive radiotherapy for head and neck squamous cell carcinoma: update and perspectives on the basis of EBM.
Jpn J Clin Oncol
; 45(3): 235-43, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25492926
20.
Etoposide and cisplatin versus irinotecan and cisplatin in patients with limited-stage small-cell lung cancer treated with etoposide and cisplatin plus concurrent accelerated hyperfractionated thoracic radiotherapy (JCOG0202): a randomised phase 3 study.
Lancet Oncol
; 15(1): 106-13, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24309370